Lee Jennifer Kayden bought RYTM
February 11, 2026 · Form 4 insider transaction
Lee Jennifer Kayden bought 32,500 shares of Rhythm Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
32,500
Price
$0.00
Total value
N/A
InsiderLee Jennifer Kayden
Role—
SecurityStock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 11, 2026
Filing dateFebruary 13, 2026
Shares owned after32,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock options were granted on February 11, 2026. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.